An Investigation into Zinc Transporter Expression in an Animal Model of Amyotrophic Lateral...
-
date post
21-Dec-2015 -
Category
Documents
-
view
212 -
download
0
Transcript of An Investigation into Zinc Transporter Expression in an Animal Model of Amyotrophic Lateral...
An Investigation into Zinc Transporter Expression
in an Animal Model of Amyotrophic Lateral Sclerosis
By Thomas Lew
Mentor: Dr. Joe Beckman
Linus Pauling Institute
Amyotrophic Lateral Sclerosis
• Results from the death of motor neurons
• Muscle degeneration
• Paralysis
• Death
http://starklab.slu.edu/signal/Growth.htm
Amyotrophic Lateral Sclerosis• Majority of ALS cases are sporadic but approximately
10% of all cases are familial• Of these familial cases, 20% of individuals inherit
dominant autosomal mutations in the SOD1 gene• SOD1 gene codes for copper-zinc superoxide
dismutase (SOD)
Superoxide
Oxygen
Superoxide
HydrogenPeroxide
e-
e-
SOD Mutations and ALS
• Over 100 different ALS causing mutations have been discovered dispersed throughout the SOD1 gene
• However, the toxicity of these mutations is not due to reduced superoxide scavenging ability
• Something about these mutations causes them to become toxic to cells
Mutant SOD and Familial ALS• Mutant SODs have a reduced affinity for binding zinc.• Copper atom in zinc-deficient SOD is much more
reactive.
Normalnerve fibre Normal
nerve fibre
Zinc-deficient SOD and ALS:Supporting Evidence
• More Cu,Zn(-)SOD in Ventral Region
• The question is - Why?
Spinal cordCross-section
Objective
The objective of this research is to investigate if a dysregulation of zinc transport pathways could account for the increased levels of zinc-deficient SOD in the ventral spinal cord
Hypothesis• Levels of zinc-deficient SOD are increased
in the ventral grey matter as a consequence of zinc transporter dysregulation
Methods• Utilize real-time Polymerase Chain Reaction (real-
time PCR) to quantify the expression of three zinc transporter genes in the dorsal and ventral grey matter of the spinal cord: i) ZnT-1 ii) ZnT-3 iii) ZnT-4
MethodsReal Time Polymerase Chain Reaction
- can be used to quantify the expression level of a specific gene.
Flu
ores
cenc
e
Time or cycle number
Add Taq polymerase, dGTP, dCTP, dATP, dTTP to synthesize complimentary strand. Add SYBR green for fluorescence
Results• Zinc Transporter 3 (ZnT-3)
– Facilitates zinc transport from the cytosol into synaptic vesicles.
ZnT-3 Gene Expression Level
0
5
10
15
Ntg Dorsal Ntg Ventral G93A Dorsal G93A Ventral
Spinal Cord Region
ZnT-3 Gene Copy Number (per 1000
_- )actin transcripts
Results• Zinc Transporter 4 (ZnT-4)
– Facilitates zinc transport from the cytosol to the Golgi apparatus and endoplasmic reticulum
ZnT-4 Gene Expression Level
0
10
20
30
40
50
Ntg Dorsal Ntg Ventral G93A Dorsal G93A Ventral
Spinal Cord Region
ZnT-4 Gene Copy Number (per 10,00 b-actin transcripts)
Results• Zinc Transporter 1 (ZnT-1)
– Facilitates zinc export from the cytosol into the extracellular space
ZnT-1 Gene Expression Level
0
20
40
60
80
Ntg Dorsal Ntg Ventral G93A Dorsal G93A Ventral
Spinal Cord Region
ZnT-1 Gene Copy Number
(per
_- )actin transcript
Summary
• ZnT1: decline in expression in ventral spinal cord of G93A vs. NTG control– Indicative of dysregulation?
•Neither ZnT-3 or ZnT-4 exhibit any change in expression level when comparing the dorsal and ventral region of the spinal cord.
• However, these results were found in 40 day old rats, and it should be noted that we have been unable to detect zinc-deficient SOD in rats younger than 50 days.
Acknowledgements
• Howard Hughes Medical Institute
• Dr. Kevin Ahern
• Dr. Joe Beckman
• Dr. Mark Levy
• The Beckman Lab